Home / Treatments / rTMS

rTMS

Transcranial Magnetic
Stimulation

Non-invasive neurostimulation using targeted magnetic pulses for treatment-resistant depression and other psychiatric conditions, in Lausanne, Switzerland.

What is TMS?

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation treatment for depression that has not responded to antidepressants. A magnetic coil held against the scalp stimulates a targeted area of the brain. No anaesthesia is needed and treatment is given on an outpatient basis at LCIP in Lausanne, Switzerland.

rTMS delivers intense magnetic pulses through a powerful electromagnet held against the scalp. The stimulation site is determined for each patient from measurements of the head.

The dynamic magnetic field produces a weak electric current, imperceptible to the patient, through electromagnetic induction, in precise brain areas and circuits involved in depression and other psychiatric or neurological conditions.

TMS increases or decreases the activity of the stimulated brain cells. TMS causes an increase in blood flow, glucose metabolism and the concentration of certain neurotransmitters (GABA, glutamate, dopamine).

The most common positioning for depression is the left or right dorsolateral prefrontal cortex, with the choice of area and parameters depending on each patient’s characteristics.

TMS does not require anaesthesia and is not painful. At most, it may cause mild headaches that respond well to ordinary painkillers.

Who is TMS indicated for?

TMS is indicated for treatment-resistant depression, or when medication is poorly tolerated, in patients of all ages.

Other promising indications:

  • Addictions (particularly cocaine)
  • Post-traumatic stress disorder (PTSD)
  • Obsessive-compulsive disorder (OCD)
  • Certain symptoms of schizophrenia (auditory verbal hallucinations, negative symptoms)
  • Fibromyalgia and chronic pain
  • Tinnitus
  • Rehabilitation after stroke
  • Generalised anxiety disorder

TMS can be combined with or followed by ketamine infusions for patients requiring a multimodal interventional approach.

Is TMS effective?

TMS has been studied in more than 80 randomised trials in depression, most of them in people for whom antidepressants had not worked.

1/2
patients show significant improvement (50% reduction in symptoms)
1/3
patients achieve complete remission after 6 weeks of treatment

TMS is an option when antidepressants have failed or are poorly tolerated. Electroconvulsive therapy (ECT) remains the most effective treatment for severe forms, but is more demanding, as each session requires general anaesthesia.

TMS has been authorised for depression in the United States since 2008, and in the United Kingdom NICE concluded in 2015 that it may be used in routine practice.

What does a TMS session involve?

Treatments are prescribed and carried out by the LCIP psychiatrists, who hold the Certificate of Advanced Training in interventional psychiatry.

The patient is comfortably seated in a chair. All metal objects sensitive to magnetic fields are removed. The fabric cap marking the stimulation site is put in place and the coil is positioned on it.

A “motor threshold measurement” procedure is carried out at the beginning of the first session to personalise the treatment intensity. The coil is then placed on the target area.

For depression, the protocol involves trains of repeated pulses lasting a few seconds, separated by pauses. A session lasts about 19 to 30 minutes depending on the protocol, and about 3 minutes with intermittent theta burst stimulation (iTBS). During treatment, the patient hears a series of clicks and feels a tapping sensation on the scalp.

Typical schedule

Standard course: one session a day, 5 days a week, for at least 4 to 6 weeks.

Some patients notice an effect within the first two weeks; for most, improvement builds gradually over the course.

Accelerated protocols: several sessions a day over 1 to 2 weeks.

Maintenance: spaced sessions if needed.

Theta burst stimulation (iTBS) shortens each session to about 3 minutes, with comparable efficacy.

The first session is always carried out by a physician. TMS protocols are designed and supervised by Dr Mall.

What are the side effects of TMS?

TMS has none of the typical side effects of antidepressants: no weight gain, sexual dysfunction, gastrointestinal problems, drowsiness, insomnia, dry mouth or excessive sweating. It does not cause memory or concentration problems either.

The most common side effect is a headache or discomfort at the stimulation site, during or after a session. It is usually mild, responds to ordinary painkillers and lessens over the sessions. Few patients stop treatment because of side effects.

Risks and contraindications

As with MRI, TMS uses an intense magnetic field and cannot be used in the presence of an implanted metal device in the skull or within 30 cm of the stimulation area (exception: dental crowns and amalgams).

Contraindications (non-exhaustive list)

  • Aneurysm clips
  • Implanted brain stimulators
  • Brain monitoring electrodes
  • Metal implants in the ears or eyes
  • Bullet or shrapnel fragments in or near the head
  • Facial tattoos with metallic or ferromagnetic ink
  • Pacemakers or implantable defibrillators (in some cases)

The main risk, which is very rare (fewer than 1 in 1,000 patients), is an epileptic seizure. This risk is considerably reduced by strict adherence to safety guidelines and the use of individualised stimulation parameters.

Can patients from other countries have TMS at LCIP?

Yes. Any treating physician can refer a patient, and consultations are held in French or English. A standard course means daily sessions over 4 to 6 weeks. Accelerated protocols, with several sessions a day over 1 to 2 weeks, shorten the stay and are discussed case by case. LCIP provides the interventional psychiatry treatment only and works in collaboration with the referring physician.

Is TMS covered by health insurance in Switzerland?

In Switzerland, compulsory basic health insurance will cover rTMS for adults with moderate to severe depression from 1 January 2028, under conditions that include two medication treatments that have not worked. Theta burst, accelerated and bilateral protocols and maintenance sessions are not covered.

Until then, TMS is not reimbursed by basic or supplementary insurance and sessions are at the patient’s expense. Information on fees is available on request.

How is the stimulation site located?

The stimulation site is determined for each patient from measurements of the head, using published methods that locate the target area from scalp landmarks. The position is marked on a fabric cap that the patient keeps for the whole course, so that the coil is placed on the same spot at every session.

LCIP is also equipped with an MRI-based neuronavigation system, which tracks the position of the coil in relation to the patient’s brain MRI.